Brennan Kahan
brennankahan.bsky.social
Brennan Kahan
@brennankahan.bsky.social
Principal Research Fellow in Medical Statistics at MRC Clinical Trials Unit at UCL. Clinical trials, estimands, estimation.
https://scholar.google.co.uk/citations?user=Lf0jsXAAAAAJ&hl=en&oi=sra
If outcome = "no. of antibiotic prescriptions" and more people in one arm get LT antibiotics (which presumably precludes further prescriptions?), this does seem like a challenge.

Could of course be good reasons for it - does highlight importance of estimands (along with justifications for choice)!
July 15, 2025 at 8:17 PM
Think they've used a treatment policy strategy (ie were interested in the effect of Hiprex vs placebo whether or not people started on suppressive antibiotics later).

I don't know enough about the area to say if this is sensible, but if suppressive antibiotics are part of usual care, it may be?
July 15, 2025 at 2:53 PM